Titrating Avidity of Yeast-Displayed Proteins Using a Transcriptional Regulator

• Published in: ACS synthetic biology Vol. 12; no. 2; pp. 419 - 431
• Main Authors: Lopez-Morales, Joanan, Vanella, Rosario, Kovacevic, Gordana, Santos, Mariana Sá, Nash, Michael A.
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 17.02.2023
• Subjects: Cell Adhesion Molecules - genetics; Fungal Proteins - genetics; Protein Engineering - methods; Saccharomyces cerevisiae - genetics; Saccharomyces cerevisiae - metabolism; Saccharomyces cerevisiae Proteins - genetics; Saccharomyces cerevisiae Proteins - metabolism; synthetic biology; enzyme engineering; protein engineering; cell adhesion; titratable yeast display; affibody; directed evolution
• ISSN: 2161-5063; 2161-5063
• DOI: 10.1021/acssynbio.2c00351

Yeast surface display is a valuable tool for protein engineering and directed evolution; however, significant variability in the copy number (i.e., avidity) of displayed variants on the yeast cell wall complicates screening and selection campaigns. Here, we report an engineered titratable display platform that modulates the avidity of Aga2-fusion proteins on the yeast cell wall dependent on the concentration of the anhydrotetracycline (aTc) inducer. Our design is based on a genomic Aga1 gene copy and an episomal Aga2-fusion construct both under the control of an aTc-dependent transcriptional regulator that enables stoichiometric and titratable expression, secretion, and display of Aga2-fusion proteins. We demonstrate tunable display levels over 2–3 orders of magnitude for various model proteins, including glucose oxidase enzyme variants, mechanostable dockerin-binding domains, and anti-PDL1 affibody domains. By regulating the copy number of displayed proteins, we demonstrate the effects of titratable avidity levels on several specific phenotypic activities, including enzyme activity and cell adhesion to surfaces under shear flow. Finally, we show that titrating down the display level allows yeast-based binding affinity measurements to be performed in a regime that avoids ligand depletion effects while maintaining small sample volumes, avoiding a well-known artifact in yeast-based binding assays. The ability to titrate the multivalency of proteins on the yeast cell wall through simple inducer control will benefit protein engineering and directed evolution methodology relying on yeast display for broad classes of therapeutic and diagnostic proteins of interest.